Disc Medicine, Inc.
IRONNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.19B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $40.00$99.50
- Volume (live)
- -
- Avg. volume (3M)
- 611.81K
Disc Medicine (IRON) Stock Price & Financial Analysis
Disc Medicine Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $55.00 - $57.24 |
|---|---|
| 52-Week High | $99.50 |
| 52-Week Low | $40.00 |
| Open | $56.56 |
| Volume (last close) | 560.58K |
| Average Volume (3M) | 611.81K |
| 50-Day MA | $72.37 |
|---|---|
| 200-Day MA | $70.87 |
| 1-Year Change | −37.01% |
| Market Cap | 2.19B |
|---|---|
| Shares Outstanding | 38.69M |
| Price to Book (P/B) | 3.40 |
| EV/EBITDA | -8.68 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Disc Medicine at a Glance
As of the Oct 16, 2026 close, Disc Medicine (IRON) has a market capitalization of $2.19B.
As of its latest reported balance sheet, it holds $98.68M in cash and securities against $60.86M of debt, a net cash position of $37.81M.
Disc Medicine does not currently pay a dividend.
The share price is down 37.0% over the past year. At $56.84 (the Oct 16, 2026 close) it sits within its 52-week range of $40.00 to $99.50, below its 200-day moving average of $70.87.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $102.22, 79.8% above the Oct 16, 2026 close.
Frequently Asked Questions About Disc Medicine
What is the current stock price for IRON?
As of the Oct 16, 2026 close, IRON stock trades at $56.84. The 52-week range is $40.00–$99.50, with a day range of $55.00–$57.24.
What is the P/E ratio for IRON?
The P/E ratio (Price-to-Earnings) for IRON is shown in the Key Statistics section. This valuation metric helps compare Disc Medicine, Inc. to industry peers.
Does IRON pay dividends?
Disc Medicine does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IRON?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for IRON is Buy. The average 12-month price target is $102.22, a 79.8% upside from the Oct 16, 2026 close of $56.84.
What is the market cap of IRON?
As of the Oct 16, 2026 close, Disc Medicine's market capitalization is $2.20B, classifying it as a mid-cap company. Disc Medicine operates in the Healthcare sector within the Biotechnology industry.